Notice2024-26267
Personnel Demonstration Project at the Defense Health Agency, Research and Development Science and Technology Reinvention Laboratory (STRL)
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
November 13, 2024
Issuing agencies
Defense Department
Abstract
This serves as notice of the proposed adoption of an STRL personnel demonstration project plan and additional flexibilities by the Defense Health Agency, Research and Development (DHA R&D), a DoD STRL. DHA R&D is an STRL comprised of medical research organizations that were formerly components of Military Department organizations, including the U.S. Army Medical Research and Development Command (USAMRDC), a successor to the U.S. Army Medical Research and Material Command (USAMRMC). The DHA R&D proposes to adopt the personnel demonstration project plan of the USAMRDC at the Federal Register issue of March 3, 1998. In addition, DHA R&D proposes to adopt certain personnel flexibilities available to all DoD STRLs.
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 219 (Wednesday, November 13, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 219 (Wednesday, November 13, 2024)]
[Notices]
[Pages 89621-89622]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-26267]
-----------------------------------------------------------------------
DEPARTMENT OF DEFENSE
Office of the Secretary
[Docket ID: DoD-2024-OS-0118]
Personnel Demonstration Project at the Defense Health Agency,
Research and Development Science and Technology Reinvention Laboratory
(STRL)
AGENCY: Under Secretary of Defense for Research and Engineering
(USD(R&E)), Department of Defense (DoD).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This serves as notice of the proposed adoption of an STRL
personnel demonstration project plan and additional flexibilities by
the Defense Health Agency, Research and Development (DHA R&D), a DoD
STRL. DHA R&D is an STRL comprised of medical research organizations
that were formerly components of Military Department organizations,
including the U.S. Army Medical Research and Development Command
(USAMRDC), a successor to the U.S. Army Medical Research and Material
Command (USAMRMC). The DHA R&D proposes to adopt the personnel
demonstration project plan of the USAMRDC at the Federal Register issue
of March 3, 1998. In addition, DHA R&D proposes to adopt certain
personnel flexibilities available to all DoD STRLs.
DATES: This proposal may not be implemented until a 30-day comment
period is provided, comments addressed, and a final Federal Register
notice published. To be considered, written comments must be submitted
on or before December 13, 2024.
ADDRESSES: You may submit comments, identified by docket number and
title, by any of the following methods:
Federal eRulemaking Portal: <a href="https://www.regulations.gov">https://www.regulations.gov</a>. Follow the
instructions for submitting comments.
Mail: Department of Defense, Office of the Assistant to the
Secretary of Defense for Privacy, Civil Liberties, and Transparency,
Regulatory Directorate, 4800 Mark Center Drive, Attn: Mailbox 24, Suite
05F16, Alexandria, VA 22350-1700.
Instructions: All submissions must include the agency name, docket
number and title for this Federal Register document. The general policy
for comments and other submissions from members of the public is to
make these submissions available for public viewing on the internet at
<a href="http://www.regulations.gov">http://www.regulations.gov</a> as they are received without change,
including any personal identifiers or contact information.
FOR FURTHER INFORMATION CONTACT:
<bullet> DHA R&D STRL: Linda Krout, 301-619-7276,
<a href="/cdn-cgi/l/email-protection#9df1f4f3f9fcb3f7b3f6eff2e8e9b3fef4ebddf5f8fcf1e9f5b3f0f4f1"><span class="__cf_email__" data-cfemail="94f8fdfaf0f5bafebaffe6fbe1e0baf7fde2d4fcf1f5f8e0fcbaf9fdf8">[email protected]</span></a>.
<bullet> Office of Under Secretary of Defense (Research and
Engineering), DoD Laboratories, Defense Research Enterprise: Julia
Parakkat, 703-625-5768, <a href="/cdn-cgi/l/email-protection#f49e81989d95da96da849586959f9f9580da979d82b499959d98da999d98"><span class="__cf_email__" data-cfemail="5a302f36333b7438742a3b283b31313b2e7439332c1a373b333674373336">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: Pursuant to section 4121 of title 10, United
States Code (U.S.C.), the Secretary of Defense is authorized to conduct
personnel demonstration projects at laboratories designated as DoD
STRLs. DoD STRLs must have an approved personnel demonstration project
plan published in an FRN and fulfill any collective bargaining
obligations before implementing the demonstration project or adopting
the flexibilities available to other DoD STRL demonstration projects.
In implementing this plan, DHA R&D will establish internal operating
procedures as appropriate.
1. Background
A personnel demonstration project was implemented at the USAMRMC in
accordance with the plan at 63 FR 10440 (March 3, 1998). In 2019, the
USAMRMC was redesignated as the USAMRDC and the personnel demonstration
project notice at 63 FR 10440 was updated through a minor modification
on August 30, 2019, to reflect this change. On May 5, 2024,
[[Page 89622]]
following the transfer of USAMRDC components to DHA R&D, the Deputy
Assistant Secretary of Defense for Science and Technology Foundations
designated DHA R&D as a DoD STRL. DHA R&D has implemented the USAMRDC
personnel demonstration project authorities for the DHA R&D components
that were formerly subordinate components of USAMRDC. This notice
proposes to implement the personnel demonstration project for all DHA
R&D components by adopting the USAMRDC personnel demonstration project
plan and other flexibilities available to all DoD STRLs.
The purpose of the demonstration project is to demonstrate that the
effectiveness of DoD organizations can be enhanced by allowing greater
managerial control over personnel functions and, at the same time,
expand the opportunities available to employees through a more
responsive and flexible personnel system.
2. DHA R&D Personnel Demonstration Project Plan
The demonstration project will cover approximately 1,224 DHA R&D
positions. Approximately 59 percent of covered positions are at the
following DHA R&D organizations located at Fort Detrick, Maryland:
Medical Research and Development, Telemedicine and Advanced Technology
Research, Medical Research Institute of Infectious Disease, Medical
Research Acquisition Activity, and Medical Materiel Development
Activity. The remaining positions are at the following sites: Medical
Research Institute of Chemical Defense, Aberdeen Proving Ground,
Maryland; Walter Reed Institute of Research, Forest Glen, Silver
Spring, Maryland; Institute of Surgical Research and the Burn Center
Directorate, Joint Base San Antonio, Texas. The majority of these
positions transferred to DHA R&D from USAMRDC. DHA R&D has successfully
implemented the USAMRDC personnel demonstration project authorities for
DHA R&D components that were formerly subordinate organizations of
USAMRDC. Based on experience gained and following careful
consideration, DHA R&D has determined to conduct a personnel
demonstration project for all DHA R&D components by adopting the
USAMRDC personnel demonstration project plan and other flexibilities
available to all DoD STRLs.
The DHA R&D will adopt the USAMRDC Personnel Demonstration Project
plan outlined in 63 FR 10440 (March 3, 1998), including the following
modifications approved pursuant to DoD Instruction 3201.05: minor
modification to administrative occupational family, DJ 03 and 04 band
structure of occupational series 1102 only (February 3, 2011); minor
modification to pay for performance payment timeframe (January 5,
2018); minor modification to participating occupational series
(November 28, 2022). Upon implementation of this personnel
demonstration project, DHA R&D will also adopt the following
flexibilities that are available to all DoD STRLs:
<bullet> 89 FR 44648 (May 21, 2024)
<bullet> 88 FR 10874 (February 22, 2023)
<bullet> 87 FR 72462 (November 25, 2022)
<bullet> 87 FR 58334 (September 26, 2022)
<bullet> 87 FR 40200 (July 6, 2022)
<bullet> 85 FR 78829 (December 7, 2020)
<bullet> 85 FR 5639 (January 31, 2020)
<bullet> 82 FR 43339 (September 15, 2017)
<bullet> 82 FR 29280 (June 28, 2017)
<bullet> 79 FR 43722 (July 28, 2014)
<bullet> 78 FR 29335 (May 20, 2013)
Dated: November 7, 2024.
Aaron T. Siegel,
Alternate OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 2024-26267 Filed 11-12-24; 8:45 am]
BILLING CODE 6001-FR-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on November 13, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.